Akèy › Ateroskleroz › Alabama › Huntsville

Etid klinik pou Ateroskleroz nan Huntsville, AL

5 etid pou Ateroskleroz ap chèche patisipan nan sit nan ak bò kote Huntsville (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Ap rekriteFaz 3

Heart Center Research LLC, Huntsville

Laj 45 a 99 · Tout sèks · Mizajou Oct 5, 2026 · NCT07037433

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

Ap rekriteFaz 2

Heart Center Research, LLC, Huntsville

Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07783802

A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis

Ap rekriteFaz 2

Heart Center Research, LLC, Huntsville

Laj 18 a 80 · Tout sèks · Mizajou Sep 22, 2026 · NCT07521007

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

Ap rekriteFaz 2/3

Nephrology Consultants, LLC, Huntsville
Nephrology of North Alabama, Decatur · 24 mi lwen

Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT05485961

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

Ap rekriteFaz 3

Research Site, Huntsville
Research Site, Athens · 22 mi lwen

Laj 18 ak plis · Tout sèks · Mizajou Aug 24, 2026 · NCT07000357

Etid Ateroskleroz nan lòt vil

Lòt etid nan Huntsville

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.